Shukra Pharmaceuticals Ltd Board of Directors
Board of Directors at Shukra Pharmaceuticals Ltd
Independent Director
Chairman & Managing Director
Executive Director
Executive Director
Independent Director
Key Highlights
- Dakshesh Shah joins the board as Chairman / Executive Director / Managing Director, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Payal Mehta continues to serve as the Executive Director in 2025, maintaining the same position as in the previous year.
- Dhruvin Shah joins the board as E D & Wholetime Director, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Sanskruti Patel joins the board as E D & Wholetime Director, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Pinki Nirmal Sagar joins the board as Independent Non Exe. Director, in a new position in 2025. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Shukra Pharmaceuticals Ltd
NSE: SHUKRAPHARMA
Share Price
Last Ten Days Market Price
| Date | |
|---|---|
| 12 Jun 2026 | 29.97 |
| 11 Jun 2026 | 29.16 |
| 10 Jun 2026 | 31.14 |
| 09 Jun 2026 | 30.78 |
| 08 Jun 2026 | 31.87 |
| 05 Jun 2026 | 31.46 |
| 04 Jun 2026 | 28.6 |
| 03 Jun 2026 | 28.94 |
| 02 Jun 2026 | 29.12 |
| 01 Jun 2026 | 29.14 |
Company Fundamentals for Shukra Pharmaceuticals Ltd
Market Cap
1,312 Cr
EPS
0.5
P/E Ratio (TTM)
59.9
P/B Ratio (TTM)
14.6
Day’s High
30.75
Day’s Low
29.5
DTE
0.1
ROE
24.6
52 Week High
65.26
52 Week Low
12.97
ROCE
31.5
Market Price of Shukra Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Shukra Pharmaceuticals Ltd News Hub
Shukra Pharmaceuticals standalone net profit rises 16.67% in the June 2024 quarter
Net profit of Shukra Pharmaceuticals rose 16.67% to Rs 0.49 crore in the quarter ended June 2024 as
Read more
13 Aug 24
Shukra Pharmaceuticals to discuss results
Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 August 202
Read more
05 Aug 24
Shukra Pharmaceuticals to hold AGM
Shukra Pharmaceuticals announced that the 31th Annual General Meeting (AGM) of the company will be h
Read more
16 Sept 24
Shukra Pharmaceuticals schedules board meeting
Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 September
Read more
24 Sept 24
